Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cheson

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Oncology (Williston Park, N.Y.)|March 17, 2001
Clinical trials referral resource. Current cooperative group phase III clinical trials in early-stage breast cancerJ Abrams, A Gravell, B Cheson
European Journal of Haematology. Supplementum|July 13, 2005
International harmonization of trial parameters in malignant lymphomaB Pfistner, V Diehl, A Greb, et al.
Oncology (Williston Park, N.Y.)|August 1, 1997
Clinical trials referral resourceB Cheson, J S Abrams, A P Nelson
Leukemia & Lymphoma|October 1, 1996
Innovative strategies for the treatment of CLLM Keating, B Cheson, J G Gribben, et al.
Seminars in Oncology|April 1, 1993
New chemotherapeutic agents in non-small-cell lung cancerE G Feigal, M Christian, B Cheson, et al.
Oncology (Williston Park, N.Y.)|July 1, 1997
Clinical trials referral resource. Clinical trials with pyrazoloacridineA J Murgo, D Cannon, M C Christian, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1981
Splenectomy for immune thrombocytopenic purpuraS J Mintz, S R Petersen, B Cheson, et al.
Blood|December 1, 1988
Prognostic factors with high-dose melphalan for refractory multiple myelomaB Barlogie, R Alexanian, L Smallwood, et al.
Cancer|December 18, 2001
Homoharringtonine: history, current research, and future directionH M Kantarjian, M Talpaz, V Santini, et al.
Blood|August 1, 1994
High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplantsD H Vesole, B Barlogie, S Jagannath, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|March 17, 2001
Clinical trials referral resource. Current cooperative group phase III clinical trials in early-stage breast cancerJ Abrams, A Gravell, B Cheson
European Journal of Haematology. Supplementum|July 13, 2005
International harmonization of trial parameters in malignant lymphomaB Pfistner, V Diehl, A Greb, et al.
Oncology (Williston Park, N.Y.)|August 1, 1997
Clinical trials referral resourceB Cheson, J S Abrams, A P Nelson
Leukemia & Lymphoma|October 1, 1996
Innovative strategies for the treatment of CLLM Keating, B Cheson, J G Gribben, et al.
Seminars in Oncology|April 1, 1993
New chemotherapeutic agents in non-small-cell lung cancerE G Feigal, M Christian, B Cheson, et al.
Oncology (Williston Park, N.Y.)|July 1, 1997
Clinical trials referral resource. Clinical trials with pyrazoloacridineA J Murgo, D Cannon, M C Christian, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1981
Splenectomy for immune thrombocytopenic purpuraS J Mintz, S R Petersen, B Cheson, et al.
Blood|December 1, 1988
Prognostic factors with high-dose melphalan for refractory multiple myelomaB Barlogie, R Alexanian, L Smallwood, et al.
Cancer|December 18, 2001
Homoharringtonine: history, current research, and future directionH M Kantarjian, M Talpaz, V Santini, et al.
Blood|August 1, 1994
High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplantsD H Vesole, B Barlogie, S Jagannath, et al.
Pageof 3